Galderma Laboratories Launches Its First Over-The-Counter Acne Regimen, Benzac® Acne Solutions

World’s Leading Dermatology Company Fights Acne by Combining Proven Acne Fighting Medicine with Breakthrough Natural Ingredients

FT. WORTH, Texas--(BUSINESS WIRE)--Galderma Laboratories, L.P., maker of Cetaphil® and the #1 prescription topical acne brand, today announced the launch of Benzac® Acne Solutions, its first-ever, over-the-counter (OTC) acne regimen. Benzac treats stubborn acne and prevents new breakouts from forming with salicylic acid, while pharmaceutical-grade East Indian Sandalwood Oil calms and soothes the skin. In a clinical study, 91% of people saw improvement in their acne in two weeks when using the new 3-step Benzac Acne Solutions, which includes the Benzac Skin Balancing Foaming Cleanser, Benzac Intensive Spot Treatment and Benzac Blemish Clearing Hydrator.

“Building on our long-standing heritage in prescription acne treatments and commitment to providing innovative dermatological solutions, Galderma is offering Benzac as an effective, non-irritating solution for the nearly 100% of teens and up to 50 million Americans who suffer from mild-to-moderate acne”

“Unlike many other acne treatments that don’t live up to their claims, Benzac is game changing in that it is clinically proven to help acne sufferers see predictable, smooth and luminous skin while minimizing irritation,” says board-certified dermatologist Dr. Jeanine Downie. “Benzac is also the only skincare line to use East Indian Sandalwood Oil, which has been used for thousands of years in Eastern medicine and is known to have antibacterial and anti-inflammatory properties and soothes the skin.”

In addition to salicylic acid, Benzac also contains Kakadu plum, an antioxidant super fruit known for having the highest natural concentration of vitamin C, to brighten the skin; lemon myrtle, a natural astringent, to help reduce excess oil; and the mineral zinc, which is shown to act as a barrier against skin moisture loss.

“Building on our long-standing heritage in prescription acne treatments and commitment to providing innovative dermatological solutions, Galderma is offering Benzac as an effective, non-irritating solution for the nearly 100% of teens and up to 50 million Americans who suffer from mild-to-moderate acne,” said Miles Harrison, Vice President and General Manager for Self Medication at Galderma Laboratories, L.P. “We want to help patients avoid the frustration of experimenting and skin irritation from multiple OTC products. If you haven’t seen improvement in your skin within two weeks of using the Benzac regimen, you should talk to your dermatologist about prescription treatment options.”

Safe for sensitive skin, Benzac is dermatologist tested, non-comedogenic (won’t clog pores) and free of artificial fragrances and dyes. It is not tested on animals. Benzac cartons are 100% recyclable, and the key ingredient in the regimen, East Indian Sandalwood Oil, is sustainably sourced.

The Benzac Complete Acne Solutions Regimen ($36.24 for the 3-step regimen)* and individual products Benzac Skin Balancing Foaming Cleanser ($14.92 for 6.0 FL OZ),* Benzac Intensive Spot Treatment ($16.84 for 0.5 FL OZ)* and Benzac Blemish Clearing Hydrator ($16.84 for 1.0 FL OZ)* are available at major retailers nationwide and online, including Benzac.com and Amazon.com.

About Galderma

Galderma is a global company founded in 1981 committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 34 wholly-owned affiliates with a worldwide network of distributors and more than 5,000 employees. Galderma’s extensive product portfolio is available in 80 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence.

With approximately 19% of revenues invested each year to discover and develop new products and access innovative technologies, the company is one of the world’s leading investors in dermatology R&D. Five state-of-the-art R&D centers and five manufacturing sites are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and efficacy.

Strategic brands in the U.S. include Cetaphil®, Epiduo®, Oracea®, Mirvaso®, Clobex®, Differin®, MetroGel®, Vectical®, Tri-Luma® and Pliaglis®.

For more information, please visit: GaldermaUSA.com

*Prices may vary: manufacturer’s suggested retail price.

Help employers find you! Check out all the jobs and post your resume.